NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 7 docx
Tài liệu Mastering Revit Architecture 2008_ Part 7 docx
... 90°
44831.book Page 1 87 Friday, October 12, 20 07 12:31 AM
Please purchase PDF Split-Merge on www.verypdf.com to remove this watermark.
PRINCIPLES OF MODELING IN REVIT
173
Figure 6.22
Early ... October 12, 20 07 12:31 AM
Please purchase PDF Split-Merge on www.verypdf.com to remove this watermark.
178
CHAPTER 6 MODELING PRINCIPLES IN REVIT
Figure 6.32
End angle is set
to 2...
Tài liệu Microsoft Office 2010 Product Guide part 7 docx
... and presence information require one of the following: Microsoft Office Communications Server 20 07 R2 with Microsoft Office Communicator 20 07 R2, Windows
Live Messenger, or another instant messaging ... meetings, and shared documents.
17
Microsoft Office Professional Plus 2010 is required to view SharePoint 2010 My Site social data. Connecting to a third-party social...
Adult Congenital Heart Disease - part 7 docx
... Rigby ML (19 97) Transcatheter umbrella closure of aorto-pulmonary window.
Heart, 77 , 479 –480.
Van Son JA, Danielson GK, Schaff HV, et al. (1993) Cor triatriatum: diagnosis, operative ap-
proach, ... Warnes CA (1996) Cebrovascular events in adult patients with cyanotic congeni-
tal heart disease. Journal of the American College of Cardiology, 28, 76 8 77 2.
Ammash NM, Connolly HM, A...
Textbook of Interventional Cardiovascular Pharmacology - part 7 docx
... and low levels of transgene
expression limit this approach. Phospholipid formulae such as
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-dode-
canoyl/1,2-dioleoyl-sn- glycero-3-phosphocholine ... intramuscular injec-
tion of recombinant adeno-associated virus-erythropoietin in
monkeys. J Surg Res 2000; 90(2):102–108.
57 Hirata RK, Russell DW. Design and packaging of adeno-associ-
ate...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 2 pdf
... II
RAVEL
SCANDSTENT
SCORPIUS
SESAMI
SIRIUS
STRATEGY
TYPHOON
Overall
3/41
1/ 12
0/54
7/80
2/ 33
9/ 72
1/11
6/19
0 /29
5/95
2/ 28
20 /131
2/ 15
1/55
59/675
1/60
0/ 12
2 /29
5/80
3/48
12/ 82
1/16
2/ 25
0 /29
4/98
6/37
15/148
3/11
2/ 61
56/736
A
B
No. at Risk
Sirolimus stent
Bare-metal ... II
RAVEL
SCANDSTENT
SCORPIUS
SESAMI
SIRIUS
STRATEGY
TYPHOON
Overall
32/ 264
5/50
8/54
10/80...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 3 pot
... animal model of venous hy-
pertension: the role of inflammation in
33 .
34 .
35 .
36 .
37 .
38 .
39 .
40.
41.
42.
43.
44.
45.
venous valve failure. J Vasc Surg 2005;41:
30 3- 1 1.
Ta ka s e S, L er on ... disability 533 /1542 (34 .6) 100 /38 1 (26.2)
Moderate disability 638 /1542 (41.4) 164 /38 1 ( 43. 0)
Severe disability 34 2/1542 (22.2) 1 03/ 381 (27.0)
Coma or vegetative state...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 4 potx
... 1
0 6-2 1-0 7
ARTIST: ts
35625 ISSUE:
0.65
0 .41
1.53
1.67
1.89
3.08
1.38
1.60
1.37
1.85
2. 04
4.18
43
35
32
34
40
53
34
45
36
53
38
56
37
42
41
29
34
44
47
23
17
14
17
20
29
16
25
17
30
19
39
16
24
24
13
18
22
21
≥10 ... 166 /47 3 (35.1) 169 /47 1 (35.9)
High cholesterol level no./total no. (%)ả 0.85
No 41 4 /46 1 (89.8) 40 4 /44 8 (90.2)
Yes 47 /46 1 (10.2) 44 /44...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 6 ppsx
... to 17.89) 0.42 66 .75 (53.04 to 80.45) 71. 36 ( 56. 66 to 86. 07) 0.45 56. 42±15.22 63 .75±14. 96 0.32
60 min after pri-
mary PCI
67 .55±22.91 51.25±24.40 16. 30 (0. 06 to 32.54) 0.04 77. 26 (61 .30 to 93.23) ... 51.52±10. 76 44.51±12.40 7.00 (−0.31 to 14.33) 0. 06 54.25 ( 46. 95 to 61 .55) 47. 96 (39. 86 to 56. 06) 0.08
6 mo after primary PCI 56. 18±10 .69 46. 19±12.21 9.99 (...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 8 pps
... (94)
Beta-blocker — no. (%)
975 (85 ) 88 7 (85 ) 705 (84 ) 363 (85 ) 10 08 (89 ) 916 (89 ) 724 (86 ) 357 (86 )
Calcium-channel blocker no. (%)Đ
459 (40) 415 (40) 360 (43) 180 (42) 488 (43) 501 (49) 4 18 (50) ...
89
26
352
3 08
272
154
58
790
84 2
551
2 98
162
16 08
1 780
1157
575
344
3614
34 58
2792
12 18
626
381 8
3 589
2917
1267
688
P=0.01
1.00
Probability...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 9 ppsx
... (mg/dl) 42.6±10.7 42 .9 11.4 42.3 9. 9 0.51
Non-HDL cholesterol (mg/dl) 1 89. 6±32.5 1 89. 7±32.3 1 89. 5±32.7 0 .96
Triglycerides (mg/dl) 197 .4±100.6 197 .7±105.6 197 .2 95 .7 0 .96
Apo B-100 (mg/dl) 152.7±23.4 ... U.S. from 199 0 through 199 9. J Am
Coll Cardiol 2000;36:205 6-6 3.
29.
Heidenreich PA, McClellan M. Trends in
the treatment and outcomes for acute myo-
cardial infarct...
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 10 potx
... inhibitors are being in-
troduced later after transplanta-
tion, to help spare renal function
by permit-
ting the
use of low-
er doses of
the calci-
neurin in-
hibitors
and to pre-
vent graft vasculopathy. ... 2002;99:760 4-9 .
Zelcer N, Khanlou N, Clare R, et al. Attenuation of neuroin-
flammation and Alzheimer’s disease pathology by liver x recep-
tors. Proc Natl Acad Sci U S A 2007...